Host: John E. Anderson, MD

Host: John Buse, MD, PhD

Host: Carol Wysham

The wintertime presents new challenges for patients with chronic diseases, specifically diabetes. But with the spread of COVID-19, how can we help keep our patients safe all winter long? Tune in to hear our Diabetes Discourse hosts Drs. Carol Wysham, John Buse, and John Anderson discuss strategies to effectively manage patients with diabetes during these winter months.

Published December X, 2020

Host: Kathy King, RDN

Guest: Megan Pesch, M.D.

Countless children across the nation are picky eaters, and families are on the lookout for effective solutions. With that in mind, Dr. Megan Pesch joins Kathy King to discuss her recent study on picky eaters and her insights on this common dilemma.

Guest: James Lindsay PhD, BM BCh, FRCP

Nutrition plays an important role in inflammatory bowel disease, but it’s important to instill in patients the understanding that even though a healthy diet can help reduce symptoms, it doesn’t mean that the disease itself has improved. Here to share how he talks about nutrition with his patients and other key management strategies like the low FODMAP diet is Dr. James Lindsay, Professor of Inflammatory Bowel Disease at Barts Health in London.

Published August 27, 2020

Host: Stacy Kahn, MD

Inflammatory bowel disease in pediatric patients is not as uncommon as you may think. Dr. Stacy Kahn, Assistant Professor of Pediatrics at Boston Children’s Hospital, shares her experience with healthy diet plans, preparing families for transition, and more.

Published August 7, 2020

Host: Kathy King, RDN

Guest: Teresa Pangan, PhD, RDN

Joining Kathy King to discuss the possible benefits and precautions of using supplemental doses of vitamin D to help fight COVID-19 is Dr. Teresa Pangan, a registered dietitian, health counselor, and keynote speaker.

Host: Abdullah Abdussalam, MD

Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s

Diana M Negoescu, Eva A Enns, PhD, Brooke Swanhorst, Bonnie Baumgartner, James P Campbell, Mark T Osterman, MD, Konstantinos Papamichael, PhD, Adam S Cheifetz, MD, Byron P Vaughn, MD

Background: Therapeutic drug monitoring (TDM) is increasingly performed for Infliximab (IFX) in patients with Crohn's disease (CD). Reactive TDM is a cost-effective strategy to empiric IFX dose escalation. The cost-effectiveness of proactive TDM is unknown. The aim of this study is to assess the cost-effectiveness of proactive vs reactive TDM in a simulated population of CD patients on IFX.

Methods: We developed a stochastic simulation model of CD patients on IFX and evaluated the expected health costs and outcomes of a proactive TDM strategy compared with a reactive strategy. The proactive strategy measured IFX concentration and antibody status every 6 months, or at the time of a flare, and dosed IFX to a therapeutic window. The reactive strategy only did so at the time of a flare.

Results: The proactive strategy led to fewer flares than the …

Host: Matt Birnholz, MD

Guest: James D. Lewis, MD, MSCE

The recipe for a healthy gut involves much more than just prescribing medications and diet restrictions. Treating the whole patient by identifying malnourishment, dermatologic conditions, and psychosocial needs can help ensure that IBD doesn’t have any negative impacts beyond the gut. Join Dr. Matt Birnholz as he digests the highlights from the 2020 Crohn's and Colitis Congress session "IBD: Beyond the Gut" with guest Dr. James Lewis.

Host: Joshua Sharfstein, MD

Host: Stephanie Desmon

Guest: Roni Neff

Bare shelves in grocery stores feed pandemic anxiety but Roni Neff, an expert on food systems and public health at the Johns Hopkins Center for a Livable Future, says this is not the biggest concern. Neff talks to Stephanie Desmon about how our robust food industry depends largely upon keeping its workers safe and well, how a pandemic completely shifts the model of emergency food access, and what’s being done to address these unique challenges to ensure everyone is fed.

Published April 16, 2020

Host: Linda Bernstein, Pharm.D.

Allergic reactions to peanut are unpredictable in occurrence and in how they present, with some individuals experiencing severe reactions from even trace amounts. Fortunately, there’s now an FDA-approved treatment option available that—when used in conjunction with peanut avoidance—can help reduce the risk of these allergic reactions in children with peanut allergy, as pharmacist Dr. Linda Bernstein explains.

Host: Maurice Pickard, MD

Guest: Christy Harrison, MPH, RD, CDN

Fad diets are extremely popular and widely used when it comes to losing weight, yet there’s often no scientific evidence to support them. That’s why Christy Harrison, author of Anti-Diet: Reclaim Your Time, Money, Well-Being, and Happiness Through INTUITIVE EATING, is here to dive into diet culture, fads, and intuitive eating.